• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离脂肪酸(FFA)受体GPR40与小鼠的高胰岛素血症、肝脂肪变性及葡萄糖稳态受损相关。

The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.

作者信息

Steneberg Pär, Rubins Nir, Bartoov-Shifman Reut, Walker Michael D, Edlund Helena

机构信息

Umeå Center for Molecular Medicine, University of Umeå, SE-901 87 Umeå, Sweden.

出版信息

Cell Metab. 2005 Apr;1(4):245-58. doi: 10.1016/j.cmet.2005.03.007.

DOI:10.1016/j.cmet.2005.03.007
PMID:16054069
Abstract

Obesity is typically associated with elevated levels of free fatty acids (FFAs) and is linked to glucose intolerance and type 2 diabetes. FFAs exert divergent effects on insulin secretion from beta cells: acute exposure to FFAs stimulates insulin secretion, whereas chronic exposure impairs insulin secretion. The G protein-coupled receptor GPR40 is selectively expressed in beta cells and is activated by FFAs. We show here that GPR40 mediates both acute and chronic effects of FFAs on insulin secretion and that GPR40 signaling is linked to impaired glucose homeostasis. GPR40-deficient beta cells secrete less insulin in response to FFAs, and loss of GPR40 protects mice from obesity-induced hyperinsulinemia, hepatic steatosis, hypertriglyceridemia, increased hepatic glucose output, hyperglycemia, and glucose intolerance. Conversely, overexpression of GPR40 in beta cells of mice leads to impaired beta cell function, hypoinsulinemia, and diabetes. These results suggest that GPR40 plays an important role in the chain of events linking obesity and type 2 diabetes.

摘要

肥胖通常与游离脂肪酸(FFAs)水平升高相关,并且与葡萄糖耐受不良和2型糖尿病有关。游离脂肪酸对β细胞的胰岛素分泌产生不同的影响:急性暴露于游离脂肪酸会刺激胰岛素分泌,而长期暴露则会损害胰岛素分泌。G蛋白偶联受体GPR40在β细胞中选择性表达,并被游离脂肪酸激活。我们在此表明,GPR40介导游离脂肪酸对胰岛素分泌的急性和慢性影响,并且GPR40信号传导与葡萄糖稳态受损有关。缺乏GPR40的β细胞对游离脂肪酸的反应分泌较少的胰岛素,GPR40的缺失保护小鼠免受肥胖诱导的高胰岛素血症、肝脂肪变性、高甘油三酯血症、肝葡萄糖输出增加、高血糖和葡萄糖耐受不良的影响。相反,在小鼠β细胞中过表达GPR40会导致β细胞功能受损、低胰岛素血症和糖尿病。这些结果表明,GPR40在连接肥胖和2型糖尿病的一系列事件中起重要作用。

相似文献

1
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.游离脂肪酸(FFA)受体GPR40与小鼠的高胰岛素血症、肝脂肪变性及葡萄糖稳态受损相关。
Cell Metab. 2005 Apr;1(4):245-58. doi: 10.1016/j.cmet.2005.03.007.
2
Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.FFAR1 点突变可消除脂肪酸依赖性胰岛素分泌,但可预防 HFD 诱导的葡萄糖不耐受。
Mol Metab. 2017 Oct;6(10):1304-1312. doi: 10.1016/j.molmet.2017.07.007. Epub 2017 Jul 18.
3
Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.G蛋白偶联受体40的选择性小分子激动剂可促进小鼠葡萄糖依赖性胰岛素分泌并降低血糖。
Diabetes. 2008 Aug;57(8):2211-9. doi: 10.2337/db08-0130. Epub 2008 May 13.
4
Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.新型 G 蛋白偶联受体 40 激动剂 DS-1558 与胰高血糖素样肽-1 受体激动剂联合增强胰岛素分泌和改善葡萄糖耐量。
Eur J Pharmacol. 2014 Aug 15;737:194-201. doi: 10.1016/j.ejphar.2014.05.014. Epub 2014 May 22.
5
GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.GPR40 蛋白水平对胰岛刺激激素分泌的调节至关重要。自发性肥胖倾向和非肥胖 2 型糖尿病大鼠模型的启示。
Mol Cell Endocrinol. 2013 Dec 5;381(1-2):150-9. doi: 10.1016/j.mce.2013.07.025. Epub 2013 Aug 2.
6
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids.G 蛋白偶联受体 40(GPR40)在人胰岛中的表达及其调控:2 型糖尿病和脂肪酸的作用。
Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):22-5. doi: 10.1016/j.numecd.2009.02.008. Epub 2009 Sep 15.
7
Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.长期用不饱和游离脂肪酸在体外处理 INS-1 大鼠胰岛β细胞,通过激活 GPR40 受体来保护细胞免受糖毒性和脂毒性。
Clin Exp Pharmacol Physiol. 2012 May;39(5):423-8. doi: 10.1111/j.1440-1681.2012.05691.x.
8
The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.脂肪酸受体GPR40在高脂喂养后的体内胰岛素分泌中发挥作用。
Diabetes. 2008 Sep;57(9):2432-7. doi: 10.2337/db08-0553. Epub 2008 Jun 16.
9
The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?脂肪酸受体 FFA1/GPR40 十年来的研究进展:我们了解多少?
Trends Endocrinol Metab. 2013 Aug;24(8):398-407. doi: 10.1016/j.tem.2013.03.003. Epub 2013 Apr 27.
10
Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.缺乏 GPR40/FFAR1 即使在胰岛素抵抗的情况下也不会导致糖尿病。
Diabetes Obes Metab. 2013 Jun;15(6):538-45. doi: 10.1111/dom.12065. Epub 2013 Feb 6.

引用本文的文献

1
Dynamics of Fatty Acid Composition in Lipids and Their Distinct Roles in Cardiometabolic Health.脂质中脂肪酸组成的动态变化及其在心脏代谢健康中的独特作用。
Biomolecules. 2025 May 10;15(5):696. doi: 10.3390/biom15050696.
2
Lc-ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia.基于液相色谱-质谱联用的非靶向代谢组学揭示了组织学慢性炎症促进前列腺增生的潜在机制。
PLoS One. 2024 Dec 23;19(12):e0314599. doi: 10.1371/journal.pone.0314599. eCollection 2024.
3
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold.
药物发现中磺内酰胺的揭秘:聚焦未充分探索的骨架。
RSC Med Chem. 2024 Apr 16;15(6):1798-1827. doi: 10.1039/d3md00653k. eCollection 2024 Jun 19.
4
The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic -Cell Function and Diabetes.G 蛋白偶联受体和受体激酶在胰腺细胞功能和糖尿病中的作用。
Pharmacol Rev. 2024 Feb 13;76(2):267-299. doi: 10.1124/pharmrev.123.001015.
5
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates.参与代谢性疾病的 G 蛋白偶联受体:药物治疗开发的最新进展。
Acta Pharmacol Sin. 2024 Jul;45(7):1321-1336. doi: 10.1038/s41401-023-01215-2. Epub 2024 Feb 7.
6
O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function.O304 通过双重促进肌肉葡萄糖效应和保护β细胞功能来改善小鼠的高血糖症。
Commun Biol. 2023 Aug 25;6(1):877. doi: 10.1038/s42003-023-05255-6.
7
Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets.葡萄糖刺激的胰岛素分泌依赖于新生鼠胰岛中的 FFA1 和 Gq。
Diabetologia. 2023 Aug;66(8):1501-1515. doi: 10.1007/s00125-023-05932-5. Epub 2023 May 23.
8
BRSK2 in pancreatic β cells promotes hyperinsulinemia-coupled insulin resistance and its genetic variants are associated with human type 2 diabetes.BRSK2 在胰腺 β 细胞中促进高胰岛素血症相关的胰岛素抵抗,其遗传变异与人类 2 型糖尿病相关。
J Mol Cell Biol. 2023 Nov 27;15(5). doi: 10.1093/jmcb/mjad033.
9
Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders.从失败中吸取教训,并对GPR40保持希望,它是一种具有强大疗效的G蛋白偶联受体靶点,可用于治疗代谢紊乱。
Front Pharmacol. 2022 Oct 25;13:1043828. doi: 10.3389/fphar.2022.1043828. eCollection 2022.
10
Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted Gene Deletion.短期ω-3 补充调节靶向基因缺失小鼠视网膜和眼动脉中新的神经血管和脂肪酸代谢蛋白质组变化。
Cells. 2022 Nov 4;11(21):3494. doi: 10.3390/cells11213494.